Related to Intranasally Delivered Exosome-Encapsulated Drugs Shown to Treat Inflammatory Brain Disorders and Cancer in Mice

• Scientists Find Hypoxia in Tumors Recruits Tregs that Promote Tolerance and Angiogenesis
  
• Ironwood Negotiates Access to Depomed’s Upper GI Drug Delivery Technology
  
• Diamyd Shifts Development Focus from Diabetes to Pain and CNS Disorders
  
• Jennerex Publishes Clinical Data Showing that Intravenously Administered Oncolytic Virus Selectively Replicates in Cancer Cells
  
• Logic-Based Synthetic Gene Circuit Developed to Identify and Selectively Kill Cancer Cells
  
• Researchers Demonstrate Viability of Targeting Intracellular Proteins with Antibodies to Treat Cancer
  
• Aura Raises $4.5M and Signs CRADA for Diagnostic and Therapeutic Nanoparticle Platform
  
• Free Radical Produced by Myeloid Cells Implicated in Blocking CTL Therapy
  
• Scientists Use Mutant Protein to Inhibit Cancer Stem Cells and Resensitize Tumors to Lapatinib
  
• Scientists Develop Dual-Function Protein Switch that Triggers Cytotoxic Cancer Prodrug
  
• NeuroVive and to-BBB Get €1M Boost to Stroke Therapy Collaboration
  
• In Vivo Studies Show CXCL12 Prevents Cancer Metastasis Through Action on CXCR4 Signaling
  
• Ablitech Gets $2M DoD Grant for R&D into Heterotopic Ossification
  
• Prostate Cancer Foundation to Help Exosome Diagnostics Fortify Development of Exosome Biofluid Test
  
• Sage Licenses Ligand’s Captisol Formulation Platform
  
• Studies Outline Mitochondrial Approach to Predicting Cancer Response to Chemotherapy
  
• Blood Platelet Contact and Signaling to Cancer Cells Found to Induce EMT and Promote Metastasis
  
• Studies Show Blocking Chaperone-Mediated Autophagy Kills Cancer
  
• Scientists Devise Sideways Approach to Killing Myc-Addicted Tumors
  
• Humoral, Cellular Activity of MUC1 Vaccine Shrinks Tumors In Vivo